| Dr Kondeh Augusta Greaves, MD DOCTOR OF MEDICIN | |
|
8700 Sudley Rd, Prince William Hospital, Manassas, VA 20110 | |
| (703) 396-5284 | |
| (703) 396-8051 |
| Full Name | Dr Kondeh Augusta Greaves |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 8700 Sudley Rd, Manassas, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790854099 | NPI | - | NPPES |
| 010036534 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101234737 (Virginia) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kondeh Augusta Greaves, MD DOCTOR OF MEDICIN 807 Santmyer Dr Se, Leesburg, VA 20175-5606 Ph: (571) 220-7450 | Dr Kondeh Augusta Greaves, MD DOCTOR OF MEDICIN 8700 Sudley Rd, Prince William Hospital, Manassas, VA 20110 Ph: (703) 396-5284 |
News Archive
A tobacco company's new, dissolvable nicotine pellet-which is being sold as a tobacco product, but which in some cases resembles popular candies-could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.
In a statement released on Monday, WHO Director-General Margaret Chan said "[s]everal recent media articles are creating misinformation and confusion in the public health arena" by "erroneously suggesting that, in working to reduce non-communicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, WHO receives funding from the food and beverage industry," the U.N. News Centre reports.
The University of Illinois at Chicago has been awarded $7 million in funding from the Patient-Centered Outcomes Research Institute to develop programs to prevent depression among teens.
A diagnosis of pancreatic cancer—the fourth most common cause of cancer death in the U.S.—can be devastating. Due in part to aggressive cell replication and tumor growth, pancreatic cancer progresses quickly and has a low five-year survival rate (less than 5 percent).
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
› Verified 9 days ago
Jennifer Kasirsky, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8700 Sudley Rd, Manassas, VA 20110 Phone: 703-369-8000 | |
Gloria Ann Grover, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8640 Sudley Road, Suite 303, Manassas, VA 20110 Phone: 703-361-7778 Fax: 703-392-6231 | |
Dr. Syamala K Naroji, MD PC Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8701 Digges Road, Manassas, VA 20110 Phone: 703-368-1138 Fax: 703-392-0415 | |
Dr. Raymond Mccue, M. D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9304 Forest Point Cir, Manassas, VA 20110 Phone: 703-368-1969 Fax: 703-369-4164 | |
Edmund S Petrilli, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9304 Forest Point Cir, Manassas, VA 20110 Phone: 703-368-1969 Fax: 703-369-4164 | |
Amy Catherine Kang, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8640 Sudley Road, Suite 303, Manassas, VA 20110 Phone: 703-361-7778 Fax: 703-392-6231 | |
Dr. Akinwunmi O Abisogun, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10701 Rosemary Dr, Manassas, VA 20109 Phone: 703-257-3001 Fax: 703-257-3133 |